BioNTech SE
BNTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001776985
In the last 90 days, BioNTech SE insiders filed 0 open-market purchases and 10 sales; 283 institutions reported holding it in 13F filings for Q2 2026, worth $4.36B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q4 2023
Institutional positions in BioNTech SE as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 282
- +32 vs. Q3 2023
- Shares held
- 40.6M
- +3.62M (+9.8%) vs. Q3 2023
- Total value
- $4.28B
- +$264.4M (+6.6%) vs. Q3 2023
- New holders
- 70
- 92 more added
- Sold out
- 38
- 69 more reduced
2 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 283 | $4.36B |
| Q1 2026 | 274 | $4.22B |
| Q4 2025 | 285 | $4.56B |
| Q3 2025 | 254 | $4.97B |
| Q2 2025 | 258 | $5.72B |
| Q1 2025 | 279 | $4.71B |
| Q4 2024 | 303 | $5.79B |
| Q3 2024 | 297 | $5.24B |
| Q2 2024 | 286 | $3.30B |
| Q1 2024 | 287 | $3.78B |
| Q4 2023 | 282 | $4.28B |
| Q3 2023 | 252 | $4.01B |
| Q2 2023 | 253 | $4.05B |
| Q1 2023 | 282 | $4.88B |
| Q4 2022 | 320 | $5.97B |
| Q3 2022 | 264 | $5.01B |
| Q2 2022 | 293 | $4.99B |
| Q1 2022 | 286 | $5.90B |
| Q4 2021 | 355 | $9.08B |
| Q3 2021 | 336 | $10.0B |
| Q2 2021 | 284 | $7.84B |
| Q1 2021 | 226 | $3.25B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding BioNTech SE; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Banque Pictet & Cie SA | 0 | $0 | 0.00% | −3,490−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −2,934−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −2,800−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −2,700−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −2,673−100.0% | Sold out |
| Independent Financial Group, LLC | 0 | $0 | 0.00% | −2,156−100.0% | Sold out |
| Vise Technologies, Inc. | 0 | $0 | 0.00% | −2,022−100.0% | Sold out |
| Saturna Capital CORP | 0 | $0 | 0.00% | −2,020−100.0% | Sold out |
| Northeast Financial Consultants Inc | 0 | $0 | 0.00% | −1,989−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −1,917−100.0% | Sold out |
| Cary Street Partner Investment Advisory LLC | 0 | $0 | 0.00% | −1,711−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −678−100.0% | Sold out |
| Baldwin Brothers Inc | 0 | $0 | 0.00% | −651−100.0% | Sold out |
| Canton Hathaway, LLC | 0 | $0 | 0.00% | −370−100.0% | Sold out |
| Itau Unibanco Holding S.A. | 0 | $0 | 0.00% | −276−100.0% | Sold out |
| Community Bank, N.A. | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Bogart Wealth, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Arrow Financial Corp | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Valley National Advisers Inc | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| First Republic Investment Management, Inc. | – | – | – | – | Not filed |
| Pathstone Family Office, LLC | – | – | – | – | Not filed |